Veterinary Medicines

Multimin Solution for Injection for Cattle

Authorised
  • Zinc oxide
  • Copper(II) carbonate
  • Sodium selenite
  • Manganese carbonate
Download as PDF

Product identification

Medicine name:
Multimin Solution for Injection for Cattle
Multimin Oplossing voor injectie
Multimin Solution injectable
Multimin Injektionslösung
Active substance:
  • Zinc oxide
  • Copper(II) carbonate
  • Sodium selenite
  • Manganese carbonate
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Zinc oxide
    74.68
    milligram(s)
    /
    1.00
    millilitre(s)
  • Copper(II) carbonate
    26.09
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium selenite
    10.95
    milligram(s)
    /
    1.00
    millilitre(s)
  • Manganese carbonate
    20.92
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CX99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Primary packaging: Clear Polyethylene Terephthalate (PET) bottle closed with grey bromobutyl rubber stopper sealed with aluminium cap.Package sizes: Cardboard box containing one vial of 500 ml
  • Primary packaging: Clear Polyethylene Terephthalate (PET) bottle closed with grey bromobutyl rubber stopper sealed with aluminium cap.Package sizes: Cardboard box containing one vial of 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Warburton Technology Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratoires Biove
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V583733
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0322/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 6/11/2025
Download
French (PDF)
Published on: 6/11/2025
Download
German (PDF)
Published on: 6/11/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 6/11/2025
Download
French (PDF)
Published on: 6/11/2025
Download
German (PDF)
Published on: 6/11/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 6/11/2025
Download
French (PDF)
Published on: 6/11/2025
Download
German (PDF)
Published on: 6/11/2025
Download

Combined File of all Documents

English (PDF)
Published on: 28/09/2025
Download